This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Genentech, Inc., Genetech, Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Iqbal Grewal: Innovator in Immune Related Disease Treatments
Introduction
Iqbal Grewal is a notable inventor based in Fremont, CA (US). He has made significant contributions to the field of immunology, particularly in the treatment of immune-related diseases. With a total of 2 patents, his work focuses on innovative methods and compositions that enhance the diagnosis and treatment of these conditions.
Latest Patents
Grewal's latest patents include "Compositions and methods for the treatment of immune related diseases." This invention relates to compositions containing a novel protein and methods for using these compositions in the diagnosis and treatment of immune-related diseases. Another significant patent is "Modulation of T cell differentiation for the treatment of T helper cell mediated diseases." This invention outlines methods for treating and diagnosing immune-related diseases, particularly those mediated by cytokines released from Th1 or Th2 cells in response to antigenic stimulation. It also discusses methods for biasing T-cell differentiation based on the expression levels of the gene TCCR and its agonists or antagonists.
Career Highlights
Throughout his career, Iqbal Grewal has worked with prominent companies such as Genentech, Inc. and Genetech, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his contributions to immunology.
Collaborations
Some of his notable coworkers include Austin L Gurney and Frederic J De Sauvage. Their collaborative efforts have played a crucial role in advancing research and development in immune-related therapies.
Conclusion
Iqbal Grewal's innovative work in the treatment of immune-related diseases showcases his dedication to improving healthcare outcomes. His patents reflect a commitment to advancing medical science and providing new solutions for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
